Hormone replacement therapy and Intraocular pressure increased
Summary:
Intraocular pressure increased is found among people with Hormone replacement therapy, especially for people who are female, 60+ old.
The study analyzes which people have Intraocular pressure increased with Hormone replacement therapy. It is created by eHealthMe based on reports of 20 people who have Hormone replacement therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Hormone replacement therapy?
Hormone replacement therapy is found to be associated with 9 drugs and 98 conditions by eHealthMe. Check the latest studies of Hormone replacement therapy.
What is Intraocular pressure increased?
Intraocular pressure increased is found to be associated with 720 drugs and 954 conditions by eHealthMe. Check the latest studies of Intraocular pressure increased.
20 people who have Hormone Replacement Therapy and Intraocular Pressure Increased are studied.

Gender of people who have Hormone Replacement Therapy and experienced Intraocular Pressure Increased *:
- female: 85 %
- male: 15 %
Age of people who have Hormone Replacement Therapy and experienced Intraocular Pressure Increased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 13.33 %
- 50-59: 40.0 %
- 60+: 46.67 %
Common co-existing conditions for these people *:
- Ocular Hypertension (intraocular pressure higher than normal): 4 people, 20.00%
- Weight Decreased: 3 people, 15.00%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 15.00%
- High Blood Cholesterol: 3 people, 15.00%
- Polyarthritis (arthritis which involves 5 or more joints simultaneously): 2 people, 10.00%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 10.00%
- High Blood Pressure: 2 people, 10.00%
- Oedema (fluid collection in tissue): 2 people, 10.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 10.00%
- Intraocular Pressure Test Abnormal: 2 people, 10.00%
Common drugs taken by these people *:
- Armour Thyroid: 3 people, 15.00%
- Testosterone: 3 people, 15.00%
- Synthroid: 3 people, 15.00%
- Xalatan: 2 people, 10.00%
- Pred Forte: 2 people, 10.00%
- Celebrex: 2 people, 10.00%
- Climara: 2 people, 10.00%
- Ketorolac Tromethamine: 2 people, 10.00%
- Levoxyl: 2 people, 10.00%
- Lipitor: 2 people, 10.00%
Common symptoms for these people *:
- Vision Blurred: 4 people, 20.00%
- Visual Impairment: 3 people, 15.00%
- Headache (pain in head): 3 people, 15.00%
- Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 15.00%
- Drug Ineffective: 3 people, 15.00%
- Overdose: 2 people, 10.00%
- Dizziness: 2 people, 10.00%
- Joint Pain: 2 people, 10.00%
- Fever: 2 people, 10.00%
- Fatigue (feeling of tiredness): 2 people, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Intraocular pressure increased?
- Check whether Intraocular pressure increased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Hormone replacement therapy (55,707 reports)
- Intraocular pressure increased (19,280 reports)
All the drugs that are associated with Intraocular pressure increased:
- Intraocular pressure increased (720 drugs)
All the conditions that are associated with Intraocular pressure increased:
- Intraocular pressure increased (954 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Intraocular pressure increased and Hormone replacement therapy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Risperdal and Quetiapine Fumarate drug interactions for men aged 30-39 - a second ago
- Could Indomethacin cause Back Disorder? - 3 seconds ago
- Paracetamol and Naproxen Sodium drug interactions for men aged 60+ - 10 seconds ago
- Acquired Immunodeficiency Syndrome and Hepatotoxicity - 11 seconds ago
- Fish Oil and Ozempic drug interactions for women aged 60+ - 17 seconds ago
- Pulmozyme and Hepatic Enzyme Increased for Boys aged 10-19 - 19 seconds ago
- Could Loraz cause Hypertransaminasaemia? - 21 seconds ago
- Paracetamol and Naproxen Sodium drug interactions for women aged 60+ - 28 seconds ago
- Drug interactions of Vitamin B3 and Doxycycline - 32 seconds ago
- Drug interactions of Lysine Acetylsalicylate and Clopidogrel - 35 seconds ago